ESR1 and breast cancer: In estrogen receptor α positive (ERα+) breast cancer (BC), ERα signaling becomes overactive leading to uncontrolled replication through activation of proliferative factors, such as cyclins, and enhanced cell survival through inhibition of apoptotic factors [1].